Cv. Putra Bali Agung
⚠️ Moderate Risk
FEI: 3007325840 • Denpasar-Bali • INDONESIA
FEI Number
3007325840
Location
Denpasar-Bali
Country
INDONESIAAddress
Jl. Bypass Ngurah Rai No. 18, , Denpasar-Bali, , Indonesia
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNSFDIETSP
The article appears to be a dietary supplement or ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.
Refusal History
Frequently Asked Questions
What is Cv. Putra Bali Agung's FDA import refusal history?
Cv. Putra Bali Agung (FEI: 3007325840) has 2 FDA import refusal record(s) in our database, spanning from 8/30/2012 to 9/21/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Cv. Putra Bali Agung's FEI number is 3007325840.
What types of violations has Cv. Putra Bali Agung received?
Cv. Putra Bali Agung has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Cv. Putra Bali Agung come from?
All FDA import refusal data for Cv. Putra Bali Agung is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.